RxDoctor Payments Data

Maulik Bhalani, MD

Interventional Pain Medicine · Wesley Chapel, FLNPI 1336331008

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,562 of the $20,401 with a category attached, or 61.6%. 38 manufacturers reported payments, led by Medtronic at 52.0% of the total. Reporting peaked in 2024 at $7,702 and has fallen 73.4% since, to $2,053 in 2025.

$20,401in general payments, 2019–2025

Across 295 payments — averaging $69.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$11K
  • Abbott$3K
  • Boston Scientific$2K
  • Stimwave Technologies Incorporated$562
  • Relievant Medsystems, Inc.$472
  • Nevro Corp.$440
  • plus $2K from 32 others

What the payments were for

  • Speaking & faculty fees$3,40017%
  • Travel & lodging$4,37121%
  • Food & beverage$12,56262%
  • Education$460%
  • Entertainment$230%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,401 in reported general payments places this provider in the 85th percentile of 278 interventional pain medicine providers in Florida.

See all interventional pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$97,251
Medicare patients
260
Services billed
894

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen421$11,244
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen381$9,227
Fentanyl68$8,439
Oxycodone Hcl193$5,053
Morphine Sulfate ErMorphine Sulfate141$3,689
Tramadol Hcl106$1,693
Pregabalin54$1,511
Morphine Sulfate45$1,038
Gabapentin16$470
Hydromorphone Hcl18$305
Acetaminophen-CodeineAcetaminophen With Codeine15$301
Diazepam17$25

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Wesley Chapel

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →